Flumedroxone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{PB}} | {{CMG}}; {{AE}} {{PB}} | ||
{{SB}} | {{SB}} | ||
==Overview== | ==Overview== | ||
Flumedroxone is a corticosteroid derivative used to treat migraines. In one study, the benefit was largely limited to women with headache associated with premenstrual syndrome. | |||
Molecular Formula being C24H31F3O4 | |||
==Category== | ==Category== | ||
Antimigraine preparations | |||
==References== | ==References== | ||
Line 36: | Line 20: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{Antimigraine preparations}} | |||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 00:49, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Synonyms / Brand Names:
Overview
Flumedroxone is a corticosteroid derivative used to treat migraines. In one study, the benefit was largely limited to women with headache associated with premenstrual syndrome.
Molecular Formula being C24H31F3O4
Category
Antimigraine preparations